John Aballi
CEO, President & DirectorMr. John Aballi serves as President, Chief Executive Officer and Director at Exagen Inc. since October 17, 2022 and served as its Interim Chief Financial Officer since August 2024 until August 31, 2024. He joined Exagen Inc. on October 2022. Most recently he served as SVP, General Manager, Urology & CLIA COO at Veracyte Inc. Mr. Aballi, who has diagnostic industry experience, is known for transforming commercial and laboratory operations and has broad experience building efficient clinical diagnostics operations. He served as Chief Operating Officer at Decipher Biosciences, Inc. since August 2018. Mr. Aballi previously served as the Head of Operations of Molecular Stethoscope from September 2015 to August 2018. Prior to joining Molecular Stethoscope, Mr. Aballi served as Head of Laboratory & Cartesian Operations of Genoptix from January 2007 to September 2015. Mr. Aballi is an executive with a broad range of experience in growth-stage companies in the clinical diagnostics arena. Mr. Aballi was a Board Member of PFS Genomics in San Diego. Mr. Aballi received his B.A. in Economics and his B.S. in Biochemistry and Cell Biology from the University of California, San Diego and his M.B.A. from California Baptist University.
Positions
- Company NameExagen Inc.Stock CodeXGNPositionCEO, President & DirectorColleagues
- TSTina S. NovaExecutive Chairman of the Board of Directors
- JGJeffrey G. BlackCFO & Corporate Secretary
- MMMichael MahlerChief Scientific Officer
- TJTina JacobsenVice President of Investor Relations
- AWArthur WeinsteinChairman of Scientific Advisory Board
- FSFrank StokesIndependent Director
- SDScott D. KahnIndependent Director
